Literature DB >> 19633770

Diagnostics of cerebral gliomas with radiolabeled amino acids.

Karl-Josef Langen1, Klaus Tatsch, Anca-Ligia Grosu, Andreas H Jacobs, Matthias Weckesser, Osama Sabri.   

Abstract

INTRODUCTION: Magnetic resonance tomography (MRT) is the investigation of choice for diagnosing cerebral glioma, but its capacity to differentiate tumor tissue from non-specific tissue changes is limited. Positron emission tomography (PET) and single photon emission computerized tomography (SPECT) using radiolabeled amino acids add information which helps increase diagnostic accuracy.
METHODS: Review based on the authors' own research results and a selective literature review.
RESULTS: The use of radiolabeled amino acids allows better delineation of tumor margins and improves targeting of biopsy and radiotherapy, and planning surgery. In addition, amino acid imaging appears useful in distinguishing tumor recurrence from non-specific post-therapeutic scar tissue, in predicting prognosis in low grade gliomas, and in monitoring metabolic response during treatment. DISCUSSION: The benefits of amino acid imaging in cerebral gliomas support arguments for its introduction into routine clinical practice in defined clinical situations; however, its influence on treatment quality remains to be demonstrated.

Entities:  

Keywords:  PET; SPECT; amino acid; brain tumors; nuclear medicine

Year:  2008        PMID: 19633770      PMCID: PMC2696728          DOI: 10.3238/arztebl.2008.0055

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN: 1866-0452            Impact factor:   5.594


  76 in total

Review 1.  Imaging of brain tumors after therapy.

Authors:  S J Nelson
Journal:  Neuroimaging Clin N Am       Date:  1999-11       Impact factor: 2.264

2.  Multiparametric 3T MR approach to the assessment of cerebral gliomas: tumor extent and malignancy.

Authors:  Alfonso Di Costanzo; Tommaso Scarabino; Francesca Trojsi; Giuseppe M Giannatempo; Teresa Popolizio; Domenico Catapano; Simona Bonavita; Nicola Maggialetti; Michela Tosetti; Ugo Salvolini; Vincenzo A d'Angelo; Giocchino Tedeschi
Journal:  Neuroradiology       Date:  2006-06-03       Impact factor: 2.804

3.  Kinetics of 3-[(123)I]iodo-l-alpha-methyltyrosine transport in rat C6 glioma cells.

Authors:  B Riemann; F Stögbauer; K Kopka; H Halfter; M Lasic; A Schirmacher; T Kuwert; M Weckesser; E B Ringelstein; O Schober
Journal:  Eur J Nucl Med       Date:  1999-10

4.  Prognostic value of O-(2-18F-fluoroethyl)-L-tyrosine PET and MRI in low-grade glioma.

Authors:  Frank W Floeth; Dirk Pauleit; Michael Sabel; Gabriele Stoffels; Guido Reifenberger; Markus J Riemenschneider; Paul Jansen; Heinz H Coenen; Hans-Jakob Steiger; Karl-Josef Langen
Journal:  J Nucl Med       Date:  2007-04       Impact factor: 10.057

5.  [Clinical value of amino acid imaging in paediatric brain tumours. Comparison with MRI].

Authors:  K Lang; S Kloska; R Straeter; C H Rickert; G Goder; G Kurlemann; A Brentrup; O Schober; M Weckesser
Journal:  Nuklearmedizin       Date:  2005       Impact factor: 1.379

6.  Can the apparent diffusion coefficient be used as a noninvasive parameter to distinguish tumor tissue from peritumoral tissue in cerebral gliomas?

Authors:  Dirk Pauleit; Karl-Josef Langen; Frank Floeth; Hubertus Hautzel; Markus J Riemenschneider; Guido Reifenberger; N Jon Shah; Hans-Wilhelm Müller
Journal:  J Magn Reson Imaging       Date:  2004-11       Impact factor: 4.813

7.  Whole-body distribution and dosimetry of O-(2-[18F]fluoroethyl)-L-tyrosine.

Authors:  Dirk Pauleit; Frank Floeth; Hans Herzog; Kurt Hamacher; Lutz Tellmann; Hans-W Müller; Heinz H Coenen; Karl-J Langen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-02-15       Impact factor: 9.236

8.  123I-IMT SPECT and 1H MR-spectroscopy at 3.0 T in the differential diagnosis of recurrent or residual gliomas: a comparative study.

Authors:  Michail Plotkin; Julia Eisenacher; Harald Bruhn; Reinhard Wurm; Roger Michel; Florian Stockhammer; Annelie Feussner; Oliver Dudeck; Peter Wust; Roland Felix; Holger Amthauer
Journal:  J Neurooncol       Date:  2004-10       Impact factor: 4.130

9.  11C-methionine uptake in cerebrovascular disease: a comparison with 18F-fDG PET and 99mTc-HMPAO SPECT.

Authors:  Makoto Nakagawa; Yasuo Kuwabara; Masayuki Sasaki; Hirofumi Koga; Tao Chen; Ouichirou Kaneko; Kazutaka Hayashi; Takato Morioka; Kouji Masuda
Journal:  Ann Nucl Med       Date:  2002-05       Impact factor: 2.668

10.  Comparison of 18F-FDG and 11C-methionine for PET-guided stereotactic brain biopsy of gliomas.

Authors:  Benoit Pirotte; Serge Goldman; Nicolas Massager; Philippe David; David Wikler; Arlette Vandesteene; Isabelle Salmon; Jacques Brotchi; Marc Levivier
Journal:  J Nucl Med       Date:  2004-08       Impact factor: 10.057

View more
  7 in total

1.  Clinical aggressiveness of malignant gliomas is linked to augmented metabolism of amino acids.

Authors:  Eduard H Panosyan; Joseph L Lasky; Henry J Lin; Albert Lai; Yang Hai; Xiuqing Guo; Michael Quinn; Stanley F Nelson; Timothy F Cloughesy; P Leia Nghiemphu
Journal:  J Neurooncol       Date:  2016-02-27       Impact factor: 4.130

2.  Asparagine depletion potentiates the cytotoxic effect of chemotherapy against brain tumors.

Authors:  Eduard H Panosyan; Yuntao Wang; Peng Xia; Wai-Nang Paul Lee; Youngju Pak; Dan R Laks; Henry J Lin; Theodore B Moore; Timothy F Cloughesy; Harley I Kornblum; Joseph L Lasky
Journal:  Mol Cancer Res       Date:  2014-02-06       Impact factor: 5.852

Review 3.  Gliomas in adults.

Authors:  Thomas Schneider; Christian Mawrin; Cordula Scherlach; Martin Skalej; Raimund Firsching
Journal:  Dtsch Arztebl Int       Date:  2010-11-12       Impact factor: 5.594

Review 4.  Tumors of the central nervous system in children and adolescents.

Authors:  Michael C Frühwald; Stefan Rutkowski
Journal:  Dtsch Arztebl Int       Date:  2011-06-03       Impact factor: 5.594

5.  Interventions to reduce the time to diagnosis of brain tumours.

Authors:  Robin Grant; Therese Dowswell; Eve Tomlinson; Paul M Brennan; Fiona M Walter; Yoav Ben-Shlomo; David William Hunt; Helen Bulbeck; Ashleigh Kernohan; Tomos Robinson; Theresa A Lawrie
Journal:  Cochrane Database Syst Rev       Date:  2020-09-04

6.  In search of druggable targets for GBM amino acid metabolism.

Authors:  Eduard H Panosyan; Henry J Lin; Jan Koster; Joseph L Lasky
Journal:  BMC Cancer       Date:  2017-02-28       Impact factor: 4.430

7.  An in vivo multimodal feasibility study in a rat brain tumour model using flexible multinuclear MR and PET systems.

Authors:  Chang-Hoon Choi; Carina Stegmayr; Aliaksandra Shymanskaya; Wieland A Worthoff; Nuno A da Silva; Jörg Felder; Karl-Josef Langen; N Jon Shah
Journal:  EJNMMI Phys       Date:  2020-07-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.